Pharmacy Podcast Network

Pharmacy Podcast Network

Details

Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care. We have over 40+ podcasts with thousands of interviews.  Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care. Join the home of the O.G. Pharmacy Podcast & discover our newest development: Evidence-based Podcasting, the first CME supplement in podcast form that's truly peer-reviewed. The future of podcasting education for Providers is "Evidence-based Podcasting" (TM) and we're building a peer-review board, reach out to us: Publisher @ Pharmacy Podcast dot com.  PPN is a division of RxPR, LLC. Copyright 2026

Recent Episodes

NOV 10, 2026
RxInfluencers – Todd Eury | CPhT Connect
In this episode of CPhT Connect, host Mike Johnston, CPhT-Adv, continues the Rx Influencer series, which spotlights the people leading the pharmacy industry, by sitting down with Todd Eury, CEO of RxPR LLC and founder, publisher, and host of the Pharmacy Podcast Network. Known as the "Rx Podfather," Todd launched the first podcast about the pharmacy profession in 2009. Today his network has produced more than 4,000 episodes and over 5 million downloads. He is also a longtime friend and media partner of NPTA. Todd is usually the one asking the questions, but in this conversation he takes the guest seat. He shares how he went from nearly a decade in telecommunications to selling software for long-term care pharmacies, and how a podcast that started as a "cheat code" for learning the industry grew into the largest podcast network dedicated to pharmacy professionals. Todd also opens up about the risks he took along the way, from a pay cut to enter pharmacy to the financial strain of going all-in on the network, as well as the controversies, online criticism, and sponsor decisions that tested what he stands for. In this episode, we discuss: * Betting on Yourself: Why Todd took a pay cut to enter pharmacy and how the "water down a hill" consistency he built in his early sales career still drives him today. * From Cheat Code to Network: How a one-episode-a-month show built to satisfy Todd's own curiosity became the Pharmacy Podcast Network, and why he says it was never about him, but about bringing in the experts. * Standing for Something: The stories behind Todd's biggest episodes, his toughest moments, and why he believes you have to decide what you will and won't stand for, even when it costs you. * A Profession at an Inflection Point: Todd's perspective on how pharmacy associations are finally collaborating, why pharmacists and technicians absorb the frustration of a system they didn't create, and what he sees coming over the next three to five years. * The Next Evolution: How RxPR, the first public relations firm dedicated exclusively to the pharmacy industry, is taking the network beyond podcasting, including a new evidence-based podcasting seal designed to bring peer-reviewed credibility to audio content. About Our Guest: Todd Eury is the CEO of RxPR LLC and the founder, publisher, and host of the Pharmacy Podcast Network, the largest podcast network dedicated to pharmacy professionals. Affectionately known as the "Rx Podfather," Todd launched the first podcast about the pharmacy profession in 2009. His network has since produced more than 4,000 episodes and over 5 million downloads, covering everything from long-term care and compounding to pediatrics, biosimilars, and cell and gene therapy. Todd's Tip Top 50 awards program, which recognizes the most influential people in pharmacy, was also a direct inspiration for NPTA's Pharmacy Technician IMPACT Awards. Listen now to hear Todd's story of building something bigger than himself, and why he believes the pharmacy profession is on the verge of a golden age. Connect with Todd Eury: Pharmacy Podcast Network: https://pharmacypodcast.com RxPR: https://rxpr.net LinkedIn: https://www.linkedin.com/in/toddeury/
63 MIN
NOV 6, 2026
CVS Breaks Apart, PBM Reform Moves Forward & the Future of Pharmacy Care | TWIRx
November 6, 2026 | Pharmacy Podcast Network Sponsored by Independent Pharmacy Cooperative (IPC) and U.S. News & World Report This week on This Week in Pharmacy, Todd Eury welcomes an outstanding lineup of pharmacy leaders, healthcare advocates, and industry experts to discuss four major developments shaping the future of pharmacy: CVS Health's historic restructuring, federal PBM reform, GLP-1 patient outcomes, and innovation in specialty medication access. Segment 1: CVS Health's Historic Separation — What Happens to 9,000 Pharmacies? CVS Health has announced plans to separate its retail pharmacy business from its PBM, insurance, and specialty pharmacy operations. What does this mean for community pharmacy profitability, patient access, and the future of vertically integrated healthcare? Guests: Greg Reybold — APCI Chichi Ilonzo Momah, PharmD, RPh — Owner, Springfield Pharmacy Alec Ginsberg — Chief Operating Officer, C.O. Bigelow Apothecaries https://drugstorecowboy.com/ The big question: If CVS is separating its pharmacies from Caremark, what does that signal about the future business model of community pharmacy? Segment 2: PBM Reform Becomes Federal Law — What's Next? Major PBM reforms were enacted through the Consolidated Appropriations Act, signed February 3, 2026, introducing new requirements for transparency, PBM compensation, and pharmacy access. Congressman Buddy Carter joins IPC's John Covello to examine the legislative victory, the work ahead to implement these reforms, and the fight to protect independent pharmacies. Guests: U.S. Representative Buddy Carter (R-GA) John Covello — Vice President of Government Relations, Independent Pharmacy Cooperative (IPC) The big question: Will federal PBM reform finally deliver meaningful financial relief and fairer competition for community pharmacies? Segment 3: GLP-1 Success — Beyond the Prescription A new U.S. News & World Report survey explores how patients select GLP-1 telehealth providers and why behavioral support, affordability, and ongoing engagement matter to long-term weight-management success. Guests: Gretel Schueller — Managing Editor, Health, U.S. News & World Report Kelli Stovall, RPh, MBA — Vice President of Clinical Strategy, Independent Pharmacy Cooperative (IPC) The big question: How can independent community pharmacists help patients achieve better outcomes beyond dispensing GLP-1 medications? Read the U.S. News GLP-1 survey Segment 4: Breaking Down Barriers to Specialty Medications — Sonexus™ Special Guest: Josh Marsh, Vice President & General Manager, Sonexus™ Access and Patient Support, Cardinal Health Josh Marsh joins Todd to discuss how Cardinal Health's Sonexus™ helps patients overcome barriers to specialty medications. The conversation explores pharmaceutical Hub Services, benefits verification, prior authorization assistance, financial support, and the growing role of AI and automation in accelerating treatment access. The big question: How can technology and personalized patient support work together to make specialty medications more accessible? Report here: https://cardinalhealth.scene7.com/is/content/corpmarketdms7prod/corp/web/documents/cardinal-health-2026-insourcing-and-outsourcing-trends-report.pdf About This Week in Pharmacy Hosted by Todd Eury, This Week in Pharmacy delivers news, policy analysis, and exclusive conversations with the professionals shaping the future of pharmacy. Sponsored by IPC and U.S. News & World Report Listen and subscribe at PharmacyPodcast.com
98 MIN
NOV 6, 2026
Follow the Money, Expose the System, Demand Accountability | PBM Reform with APCI
In this special edition of the PBM Reform Podcast, host Greg Reybold welcomes nationally recognized drug pricing expert Antonio Ciaccia for an unfiltered conversation about pharmacy benefit managers (PBMs), hidden financial incentives, and the growing movement toward meaningful reform. Ciaccia has spent years investigating the economics of prescription drug distribution, helping uncover hundreds of millions of dollars in questionable Medicaid drug spending and exposing the financial mechanisms behind inflated drug prices. His latest work with 3 Axis Advisors raises important questions about whether conventional PBM contracts deliver the savings they promise. An October 2026 analysis compares Mark Cuban Cost Plus Drug Company's published prices with traditional PBM pricing arrangements. Another June 2026 report examines how retrospective rebates, pricing benchmarks, and administrative arrangements create financial risks for employers and health plans. Ciaccia has also described three forces capable of driving PBM reform: legislation, litigation, and market-based competition. As he told Drug Topics, borrowing a familiar expression from Greg Reybold: “Pressure busts pipes.” In This Episode Why PBM pricing transparency remains essential for employers, patients, and pharmacies. What recent drug pricing research reveals about hidden costs and contractual complexity. How cost-plus pharmacy models challenge traditional PBM economics. Why independent pharmacies continue facing reimbursement and cash-flow pressures. Whether federal reform and marketplace competition can produce lasting accountability. How pharmacists, employers, and policymakers can demand measurable results. The future of pharmacy benefits depends on more than promises of reform. It demands transparency, accountability, and evidence that savings actually reach the people paying for healthcare. Join Greg Reybold and Antonio Ciaccia as they follow the money and examine what's next for PBM reform.
52 MIN